Skip to the page

Data / Drug companies / Noramco, LLC

Noramco, LLC: 15 products in the FDA NDC directory, labeler code 51634

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Noramco, LLC (labeler code 51634) lists 15 products in the FDA National Drug Code Directory. By type: 15 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 1, 2025.

The request: Watch Noramco, LLC (FDA labeler code 51634): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
51634
Products in commercial distribution
15
Packages
18
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule II 9, Schedule III 2
Started marketing in the last 12 months
0
Earliest marketing start
June 6, 1986
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients15100%

Products by type

TypeProductsShare
Bulk ingredients15100%

Dosage forms

Dosage formProductsShare
Powder15100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Buprenorphine51634-1039PowderBulk ingredientsSeptember 1, 2025
Naloxone hydrochloride dihydrate51634-2018PowderBulk ingredientsJune 1, 2025
Methylnaltrexone bromide51634-3248PowderBulk ingredientsJuly 12, 2024
Naltrexone base51634-1060PowderBulk ingredientsMarch 8, 2024
Naltrexone hydrochloride51634-1064PowderBulk ingredientsJanuary 5, 2024
Lisdexamfetamine dimesylate51634-2058PowderBulk ingredientsDecember 10, 2021
Methylphenidate hydrochloride51634-0114PowderBulk ingredientsJuly 31, 2017
Buprenorphine hydrochloride51634-0608PowderBulk ingredientsJuly 26, 2017
Oxymorphone hydrochloride51634-0095PowderBulk ingredientsJune 17, 2009
Purified oxycodone base51634-0003PowderBulk ingredientsFebruary 21, 2008
Hydromorphone hydrochloride51634-0057PowderBulk ingredientsJune 29, 2006
Morphine sulfate51634-0969PowderBulk ingredientsJanuary 1, 2000
Oxycodone hydrochloride51634-0002PowderBulk ingredientsJanuary 1, 2000
Hydrocodone bitartrate51634-0014PowderBulk ingredientsJuly 24, 1987
Codeine phosphate51634-0999PowderBulk ingredientsJune 6, 1986

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.